Eventide Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

$5.67 Billion
Q3 2024

A detailed history of Eventide Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 272,954 shares of SRPT stock, worth $34.3 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

272,954

Previous 228,529 19.44%

Holding current value

$34.3 Million

Previous $36.1 Million 5.58%

% of portfolio

0.6%

Previous 0.64%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $5.52 Million - $6.96 Million	44,425 Added 19.44%	272,954 $34.1 Million
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $10.5 Million - $15.2 Million	93,063 Added 68.7%	228,529 $36.1 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $4.33 Million - $6.55 Million	46,247 Added 51.84%	135,466 $17.5 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $2.25 Million - $4.17 Million	-33,424 Reduced 27.25%	89,219 $8.6 Million
Q2 2023 Aug 15, 2023	SELL	$106.4 - $157.19 $6.88 Million - $10.2 Million	-64,625 Reduced 34.51%	122,643 $14 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $22 Million - $29.2 Million	187,268 New	187,268 $25.8 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $48.4 Million - $60.5 Million	-697,156 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $16.9 Million - $39.6 Million	-234,356 Reduced 25.16%	697,156 $52 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $8.2 Million - $11.1 Million	-64,488 Reduced 6.47%	931,512 $131 Million
Q4 2019 Jan 29, 2020	SELL	$76.53 - $135.58 $17.1 Million - $30.2 Million	-223,000 Reduced 18.29%	996,000 $129 Million
Q3 2019 Nov 21, 2019	BUY	$72.81 - $156.91 $6.99 Million - $15.1 Million	96,000 Added 8.55%	1,219,000 $91.8 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $31.2 Million - $42.2 Million	277,832 Added 32.87%	1,123,000 $171 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $21.9 Million - $33.5 Million	225,168 Added 36.32%	845,168 $92.2 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $28.3 Million - $39.6 Million	245,000 Added 65.33%	620,000 $100 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $10.7 Million - $22.9 Million	149,000 Added 65.93%	375,000 $49.6 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $3.51 Million - $5.35 Million	65,000 Added 40.37%	226,000 $16.7 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $5.75 Million - $7.59 Million	161,000	161,000 $7.3 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Account

Eventide Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History